Aram Hambardzumyan

Aram Hambardzumyan practices at Mercy Medical Center Redding in Redding, California, part of CommonSpirit Health.

Aram Hambardzumyan's NPI, 1952807851, was assigned on April 1, 2018. Aram Hambardzumyan holds California license A173734.

Aram Hambardzumyan's primary practice is Mercy Medical Center Redding, at 2175 Rosaline Ave, Clairmont Hgts, Redding, CA 96001 in Shasta County. The practice phone is (530) 225-6102.

Aram Hambardzumyan's primary practice is Mercy Medical Center Redding in Redding, California, part of CommonSpirit Health. Aram Hambardzumyan is also affiliated with Shasta Regional Medical Center. The medical group on file is Vituity. Dmand AI also links Aram Hambardzumyan to 3 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Aram Hambardzumyan practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Aram Hambardzumyan's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Aram Hambardzumyan is licensed in California.

CMS data shows 1,014 Medicare services from Aram Hambardzumyan across 6 procedure codes in 2024, for 590 Medicare patients. Medicare paid $103,956 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 590 Medicare patients who saw Aram Hambardzumyan in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Aram Hambardzumyan's median patient age at 67, with 57% women.

In 2021, Aram Hambardzumyan wrote 14 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $45 in total drug cost. In 2020, CMS named 47 claims across 3 drugs.

Aram Hambardzumyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Aram Hambardzumyan as offering telehealth.

CMS Open Payments shows 2 general payments to Aram Hambardzumyan from 1 drug or device company from 2018 to 2019. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $206.